Inven Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Indore., Madhya Pradesh, India, established in 1984.
1984 Indore., Madhya Pradesh, India Active
Last Updated:
Access Report
About Inven Pharmaceuticals Private Limited

Inven Pharmaceuticals Private Limited, a active private limited company, was established on 24 December 1984 in Indore., Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1984PTC002701. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹3.20 M.

It upholds a compliant status. Employing 85 professional, Its leadership includes Urvashi Patni (Managing Director), Manju Patni (Whole-Time Director), Sohil Patni (Whole-Time Director). Past directors included Lalchand Patni, Urvashi Patni, Sohil Patni. It holds ₹9.02 Cr open charges and ₹1.60 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 27/1, Patel Nagar Main Road,, Indore., Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP1984PTC002701

  • Registration Number

    002701

  • Incorporation Date

    24 December 1984

  • Authorized Capital

    ₹4.50 M

  • Paid-Up Capital

    ₹3.20 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.50 M
  • Paid Up Capital ₹ 3.20 M
  • Company Age 41 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9.02 Cr
  • Satisfied Charges ₹ 1.60 Cr
  • Revenue Growth **** 13.36%
  • Profit Growth **** 181.47%
  • Ebitda **** -7.06%
  • Net Worth 1.21%
  • Total Assets -2.81%
Company report

Inven Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Inven Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Inven Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Urvashi Patni Managing Director 05 Nov 2024 Current
Manju Patni Whole-Time Director 17 Jun 2006 Current
Sohil Patni Whole-Time Director 05 Nov 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 24 Jul 2018 Past
Pramod Abcsdd Whole-Time Director 29 Sep 2016 Past
Pramod Abcsdd Whole-Time Director 01 Jun 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Inven Pharmaceuticals.

Inven Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.36% increase. The company also saw a substantial improvement in profitability, with a 181.47% increase in profit. The company's net worth moved up by a moderate rise of 1.21%.

Inven Pharmaceuticals revenue growth over time
Inven Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.36%
*******
*******
*******
*******
Revenue from Operations
*******
 13.58%
*******
*******
*******
*******
Total Assets
*******
 -2.81%
*******
*******
*******
*******
Profit or Loss
*******
 181.47%
*******
*******
*******
*******
Net Worth
*******
 1.21%
*******
*******
*******
*******
EBITDA
*******
 -7.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Inven Pharmaceuticals?

In 2023, Inven Pharmaceuticals had a promoter holding of 99.22% and a public holding of 0.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹90,192,000.00

Satisfied Charges

₹16,035,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 9.00 Cr
  • State Bank Of Indore : 0.02 Cr
Latest Charge Details
Date Lender Amount Status
10 Dec 2009 Hdfc Bank Limited ₹9.00 Cr Open
29 Oct 1990 State Bank Of Indore ₹0.19 M Open
17 Jan 1995 State Bank Of Indore ₹1.00 M Satisfied
17 Jan 1995 State Bank Of Indore ₹1.50 M Satisfied
29 Mar 1994 Madhya Pradesh Finance Corporation ₹1.10 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Inven Pharmaceuticals?

Inven Pharmaceuticals has a workforce of 85 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Inven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inven Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Inven Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Inven Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Inven Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was documented.

  • Director Appointment

    The activity Urvashi Patni was appointed as a Managing Director was appointed as a Managing Director on 05 Nov 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 90.00 M registered on 10 Dec 2009 with Charge ID 10193794 was modified on 26 Oct 2018. was completed.

  • Charges

    The activity A charge registered on 29 Mar 1994 via Charge ID 90204943 with Madhya Pradesh Finance Corporation was fully satisfied on 07 Mar 2017. was completed.

  • Charges

    The activity A charge registered on 29 Mar 1994 via Charge ID 90207454 with Madhya Pradesh Finance Corporation was fully satisfied on 07 Mar 2017. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Inven Pharmaceuticals Private Limited?

The CIN of Inven Pharmaceuticals Private Limited is U24232MP1984PTC002701.

Where is Inven Pharmaceuticals Private Limited headquartered?

Inven Pharmaceuticals Private Limited is headquartered at 27/1, Patel Nagar Main Road,, Indore., Madhya Pradesh, 452001.

When was Inven Pharmaceuticals Private Limited incorporated?

Inven Pharmaceuticals Private Limited was incorporated on 24 December 1984.

Who are the current directors of Inven Pharmaceuticals Private Limited?

The current directors of Inven Pharmaceuticals Private Limited are

What is the primary industry of Inven Pharmaceuticals Private Limited?

The primary industry of Inven Pharmaceuticals Private Limited is Manufacturing.

Is Inven Pharmaceuticals Private Limited a listed company?

Inven Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Inven Pharmaceuticals Private Limited?

The authorized capital of Inven Pharmaceuticals Private Limited is ₹4.50 M, and the paid-up capital is ₹3.20 M.

What is the compliance status of Inven Pharmaceuticals Private Limited?

The compliance status of Inven Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available